tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
InnoCan Pharma (INNPF)
OTHER OTC:INNPF
INNPF
InnoCan Pharma
Stock Analysis
Technical Analysis
Chart
Earnings
Dividends
Ownership
Financials
News & Insights
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Holding INNPF?
Track your performance easily
Link Broker

InnoCan Pharma (INNPF) Stock News & Sentiment

11 Followers
Innocan Pharma Highlights FDA Milestones and New Website
Premium
Company Announcements
Innocan Pharma Highlights FDA Milestones and New Website
3d ago
Innocan Pharma’s LPT-CBD Eases Dog Arthritis Pain
Premium
Company Announcements
Innocan Pharma’s LPT-CBD Eases Dog Arthritis Pain
8d ago
InnoCan Pharma’s Advisor Among Top Cited Scientists
Premium
Company Announcements
InnoCan Pharma’s Advisor Among Top Cited Scientists
10d ago
Innocan Pharma’s LPT-CBD Nears FDA Approval
Premium
Company Announcements
Innocan Pharma’s LPT-CBD Nears FDA Approval
2M ago
InnoCan Pharma Subsidiary Triumphs with FDA and Announces Private Placement
Premium
Company Announcements
InnoCan Pharma Subsidiary Triumphs with FDA and Announces Private Placement
2M ago
InnoCan Pharma Soars with Strong Q2 2024 Financials
Premium
Company Announcements
InnoCan Pharma Soars with Strong Q2 2024 Financials
2M ago
InnoCan Pharma Advances Veterinary CBD Drug with FDA Nod
Premium
Company Announcements
InnoCan Pharma Advances Veterinary CBD Drug with FDA Nod
3M ago
More INNPF News >

INNPF News on the Web

Innocan Pharma to Participate at the ThinkEquity 2024 Investor Conference in New York Also Announces Relaunch of Updated Website for Enhanced Investor Experience
Yahoo Finance
Neutral
Innocan Pharma's LPT-CBD Shows Long-Term Success in Relieving Osteoarthritis Pain in Dogs
Yahoo Finance
Neutral
Innocan Pharma Celebrates Dr. Joseph Pergolizzi's Recognition Among Stanford University's List of the Top 2% Most-Cited Scientists Worldwide
Yahoo Finance
Neutral
Innocan Pharma Advances Liposomal CBD with Positive Response from FDA Following Successful Pre-IND Meeting
Yahoo Finance
Neutral
Innocan Pharma Announces Closing of Private Placement and Grant of Stock Options
Yahoo Finance
Neutral
Innocan Pharma's Subsidiary BI Sky Global Successfully Completes FDA MoCRA Registration
Yahoo Finance
Neutral
Innocan Pharma Reports Second Quarter 2024 Results with Revenue Growth of over 2.8X to $8.6 Million
Yahoo Finance
Neutral
InnoCan Pharma Advances Veterinary CBD Drug with FDA Nod
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
INNPF
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is INNPF’s Media Buzz Sentiment?
1 articles about INNPF were published this week. In an average week, 1 articles are published.
    What is INNPF’s weekly average amount of articles?
    In an average week, 1 articles about INNPF are published.
      What is INNPF’s News Sentiment?
      50% of articles about INNPF were positive this week, compared to its sector average of 58%.
        Healthcare Stocks that are Trending in the News
        LBPHLongboard Pharmaceuticals
        ELVElevance Health
        APPHAPONTIS PHARMA AG
        JAZZJazz Pharmaceuticals
        ABTAbbott Laboratories
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing